LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Siemens Highlights Presents Latest Breakthroughs in Healthcare

By LabMedica International staff writers
Posted on 03 Feb 2025
Image: Laboratories can experience integrated automation in 6m2 on the Atellica Solution (Photo courtesy of Siemens)
Image: Laboratories can experience integrated automation in 6m2 on the Atellica Solution (Photo courtesy of Siemens)

Siemens Healthineers (Forchheim, Germany) is presenting its transformative healthcare solutions at Medlab Middle East 2025 that are designed to empower professionals to provide the highest level of care to their patients.

Siemens is highlighting various products highlighted including its two new high-volume hematology analyzers, the Atellica HEMA 570 and 580. Designed to meet the hematology testing needs of today’s high-volume labs, both instruments share fast throughput and an identical footprint. Also featured at the event is the IMMULITE 2000 XPi immunoassay system that provides multiple tests on a single, easy-to-use analyzer. This makes it simple to adjust to changes in demand and scale capabilities without disrupting day-to-day operations. Additionally, Siemens is presenting the CN-3000 and CN-6000 coagulation designed to meet the small-sized, mid- and high-volume hemostasis testing solutions. The CN Systems leverage optical testing methodology with intelligent software to automate and standardize sample management for reliable results, reduced repeat testing, and reagent waste. Siemens is also highlighting Atellica Integrated Automation which consolidates revolutionary sample management technology, intelligent software, and IT to provide workflow efficiency with the flexibility to add decapping with little or no additional footprint.

Among its compact solutions featured at the event is the Atellica DCA Analyzer which puts fast, quality HbA1c and ACR results right at the fingertips. Experience the performance and precision you need to improve outcomes. Designed with the speed, standardization, and personalization required to boost efficiencies and meet growing demand, the Atellica DCA Analyzer can be placed wherever it is needed when space is at a premium. Also featured at the event is the RAPIDPoint 500e System that elevates Siemens’ blood gas offering to a new level. This end-to-end blood gas solution reduces the daily burden of device management and enables healthcare professionals to give full care and attention to their patients. Moreover, Siemens is also demonstrating the Atellica VTLi patient-side immunoassay analyzer for high-sensitivity troponin testing at the point of care. It produces accurate results in just 8 minutes, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Silver Member
PCR Plates
Diamond Shell PCR Plates

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more